Bayer Crop Science once again hosted its annual #AgVocacy Forum to kick off this year’s Commodity Classic, with two days of educational sessions on the importance of telling agriculture’s story occurring in the days leading up to Commodity Classic. The ZimmComm team enjoyed this year’s Forum as much as last year’s. It was incredibly well done, informative, and full of …
Beyond the Farm Gate – It’s All About Passion
This is the 12th year Bayer CropScience has brought a diverse group of ag voices together to talk about key agricultural issues and the importance of advocating for our industry. One panel during the 2017 Bayer AgVocacy Forum brought a team of farmers together to discuss Beyond the Farm Gate: Today’s Challenges Create Tomorrow’s Opportunities. Panelist included: Deb Gangwish, Co-Owner, …
LibertyLink Real Yield Sweepstakes Winners at #Classic17
Last year was the second year for the LibertyLink Real Yield Sweepstakes, which gave away 200 acres of LiberyLink soybeans or cotton to two growers each month. The grand prize winner for the year was Gary Tretter from Illinois, who received the 500 acre grand prize and a trip to Commodity Classic in San Antonio last week, along with the other …
Credenz Going Big from #Classic17
Monty Malone was in San Antonio for Commodity Classic to talk to growers about the latest in Credenz soybeans. Last year more than 500 trials in 6 states showed that, when compared head-to-head, Credenz LibertyLink soybeans offered a 2.2 bu/A yield advantage over Asgrow Roundup Ready 2 Xtend beans. Next year the company is going even bigger with 10 new …
Bayer/Monsanto Excited About the Future
Adrian Percy, head of research and development at Bayer CropScience, and Robb Fraley, Monsanto chief technology officer held an informal press conference at Commodity Classic to discuss the proposed nuptials of their companies. Both Percy and Fraley spoke highly of Monsanto’s seeds and traits and Bayer’s chemistry, but took pains to point out how much better they will be when …
LibertyLink Finds Partners in FFA and AHA
LibertyLink may not immediately make you think of the American Heart Association (AHA), but Bayer wants to change that. “So our goal is to build awareness around heart disease– one of the major killers in the rural market,” explains Jody Wynia, soybean and cotton manager for Bayer. “It’s 39 percent more prevalent in rural communitites than it is in the …
Funding the Next Ag Food Revolution
There is no question that the world is entering a new agricultural food revolution, with new technological innovations remaining necessary in order to solve the many current and future problems facing global food security and sustainability. Several panelists were brought in during the 2017 Bayer #AgVocacy Forum to discuss how the industry is going to be able to fund the …
An #AgVocate Example to Feed the Future
What better department than R&D to fulfill the 2017 AgVocacy Forum theme “Feed the Future.” In charge of that department for Bayer CropScience is Dr. Adrian Percy. Adrian has embraced the use of social media to help communicate to consumers, regulators and others, the benefits of the type of work Bayer does. He has been a real positive example for …
Bayer Talks Policy – Trade, WOTUS, Farm Bill
News from Washington comes daily and every decision in one way, shape or form impacts our agriculture community. The Bayer AgVocacy Form provided a platform for key policy issues to be discussed and Bayer’s Federal Relations and Policy Senior Director, Jim McVaney, shared his insights into the new administration. “The fact that agriculture didn’t play a role in the President’s …
Bayer Offers Outlook on Industry, Monsanto Acquisition
When it comes to scientific innovation, Bayer has a longstanding reputation as a leader in the development of breakthrough technologies. New innovations, developments, and changes are always on the horizon for Bayer, and the company’s dynamic outlook was discussed during the 2017 Bayer AgVocacy Forum in a presentation from Dr. Adrian Percy, Bayer’s global head of research & development and …